Baird Downgrades Voyager Therapeutics (VYGR) to Neutral
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Price: $3.41 --0%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 9
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 9
Join SI Premium – FREE
Baird analyst Brian Skorney downgraded Voyager Therapeutics (NASDAQ: VYGR) from Outperform to Neutral with a price target of $6.00.
For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.
Shares of Voyager Therapeutics closed at $6.23 yesterday.
You May Also Be Interested In
- Citi cuts TJX Companies rating to Neutral, lowers price target
- CLSA Downgrades Tech Mahindra Ltd. (TECHM:IN) to Hold (3)
- CLSA Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underperform (4)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
